C

CinnaGen

Perfil gerido pelo Bizz Id
Irão 1994

Descrição

A CinnaGen é um grupo biofarmacêutico iraniano que desenvolve e fabrica medicamentos biológicos —proteínas recombinantes, anticorpos monoclonais e biossimilares— para autoimunidade, oncologia, neurologia, endocrinologia e infertilidade. Tem sede em Teerão e fábrica em Karaj; segundo o seu site, os seus medicamentos chegam a mais de 70 países.

Produtos

32 produtos
Adalimumab

Brand: CinnoRA (40 mg). 40 mg/0.8 mL autoinjector. Rheumatoid arthritis and other inflammatory diseases.

Produto acabado

Verificado a 2026-10-21

Adalimumab: see suppliers →

Aflibercept

Brand: Tyalia (40 mg). Intravitreal injection. Wet AMD, diabetic macular oedema, diabetic retinopathy and other eye conditions.

Produto acabado

Verificado a 2026-10-21

Aflibercept: see suppliers →

Amphotericin B, Liposome for Injection

Brand: Alentiva (50 mg). Antifungal. Severe systemic and/or deep mycoses (disseminated candidiasis, aspergillosis, cryptococcosis, chronic mycetoma, mucormycosis) in adults and children from 1 month.

Produto acabado

Verificado a 2026-10-21

Amphotericin B: see suppliers →

Buserelin Acetate

Brand: CinnaFact (1 mg). Synthetic peptide GnRH analogue. Endometriosis and infertility treatment.

Produto acabado

Verificado a 2026-10-21

Buserelin: see suppliers →

Cetrorelix Acetate

Brand: Lixafert (250 mcg). Prevention of premature ovulation in assisted reproductive techniques.

Produto acabado

Verificado a 2026-10-21

Cetrorelix: see suppliers →

Cetuximab

Brand: Araxya (5 mg). Monoclonal antibody. Metastatic large intestine cancer (alone or in combination, including with encorafenib in BRAF-mutant disease) and head and neck cancer.

Produto acabado

Verificado a 2026-10-21

Cetuximab: see suppliers →

Daratumumab

Brand: Acravia (100 mg, 400 mg). Human anti-CD38 monoclonal antibody. Newly diagnosed and relapsed/refractory multiple myeloma.

Produto acabado

Verificado a 2026-10-21

Daratumumab: see suppliers →

Eculizumab

Brand: Ablyze (10 mg). Humanized IgG monoclonal antibody binding complement C5. PNH, aHUS, generalized myasthenia gravis and NMOSD.

Produto acabado

Verificado a 2026-10-21

Eculizumab: see suppliers →

Enoxaparin sodium

Brand: CinnaStim (2000–10000 IU). Syringes. Treatment and prevention of blood clots (peri-operative, immobilisation) and unstable angina.

Produto acabado

Verificado a 2026-10-21

Enoxaparin: see suppliers →

Epoetin beta

Brand: Cinnapoietin (erythropoietin β). Recombinant human erythropoietin produced in CHO cells, prefilled syringes. Anaemia of chronic kidney disease, autologous blood pre-donation and prevention of anaemia of prematurity.

Produto acabado

Verificado a 2026-10-21

Epoetin: see suppliers →

Evolocumab

Brand: Eldona (140 mg). Monoclonal antibody. Reduction of major adverse cardiovascular events in high-risk adults and hyperlipidaemia.

Produto acabado

Verificado a 2026-10-21

Evolocumab: see suppliers →

Filgrastim

Brand: Nowaria (300 mcg/0.5 mL prefilled syringe). Chemotherapy-induced myelosuppression, AML, bone marrow transplantation, acute radiation syndrome and progenitor cell mobilisation.

Produto acabado

Verificado a 2026-10-21

Filgrastim: see suppliers →

Follitropin alfa

Brand: Cinnal-f (75, 150, 300, 450, 900 IU). Prefilled pen. Ovarian stimulation, assisted reproductive technology and anovulation (with lutropin alfa).

Produto acabado

Verificado a 2026-10-21

Follitropin alfa: see suppliers →

Glatiramer Acetate

Brand: Cinnomer (20, 40 mg). Relapsing forms of multiple sclerosis.

Produto acabado

Verificado a 2026-10-21

Glatiramer: see suppliers →

Guselkumab

Brand: Eldixia (100 mg). Human IgG1 monoclonal antibody in prefilled syringe. Moderate to severe plaque psoriasis in adults.

Produto acabado

Verificado a 2026-10-21

Guselkumab: see suppliers →

Insulin glargine

Brand: Gylava (100 IU). Diabetes mellitus in adults, adolescents and children aged 2 and above.

Produto acabado

Verificado a 2026-10-21

Insulin glargine: see suppliers →

Interferon beta-1a (22/44/132 mcg)

Brand: ReciGen (22, 44, 132 mcg). Prefilled syringe. Relapsing forms of multiple sclerosis.

Produto acabado

Verificado a 2026-10-21

Interferon beta-1a: see suppliers →

Interferon beta-1a (30 mcg)

Brand: CinnoVex (30 mcg). Relapsing multiple sclerosis.

Produto acabado

Verificado a 2026-10-21

Interferon beta-1a: see suppliers →

Laronidase

Brand: Herozyme (580 mcg). Enzyme replacement. Non-neurological manifestations of mucopolysaccharidosis type I (MPS I).

Produto acabado

Verificado a 2026-10-21

Laronidase: see suppliers →

Liraglutide (type 2 diabetes)

Brand: Melitide (6 mg/mL). GLP-1 analogue. Type 2 diabetes in adults and children aged 10+ and cardiovascular risk reduction.

Produto acabado

Verificado a 2026-10-21

Liraglutide: see suppliers →

Liraglutide (weight management)

Brand: Maciza (6 mg/mL; 18 mg/3 mL pen). GLP-1 analogue. Weight management in adults with obesity or overweight with comorbidity.

Produto acabado

Verificado a 2026-10-21

Liraglutide: see suppliers →

Nivolumab

Brand: Xtramab (40, 100, 240 mg). Fully human IgG4 anti-PD-1 monoclonal antibody. Melanoma, NSCLC and other cancers.

Produto acabado

Verificado a 2026-10-21

Nivolumab: see suppliers →

Ocrelizumab

Brand: Xacrel (30 mg). Humanized anti-CD20 monoclonal antibody. Relapsing and primary progressive multiple sclerosis.

Produto acabado

Verificado a 2026-10-21

Ocrelizumab: see suppliers →

Omalizumab

Brand: Zerafil (150 mg). Anti-IgE monoclonal antibody. Moderate to severe persistent allergic asthma, chronic spontaneous urticaria and other indications.

Produto acabado

Verificado a 2026-10-21

Omalizumab: see suppliers →

Pegfilgrastim (3 mg)

Brand: KidiPeg. 3 mg/0.3 mL prefilled syringe (product list shows "10, 50 mg"). Decreases infection (febrile neutropenia) in non-myeloid malignancies on myelosuppressive therapy.

Produto acabado

Verificado a 2026-10-21

Pegfilgrastim: see suppliers →

Pegfilgrastim (6 mg)

Brand: PegaGen (6 mg). Prevention of chemotherapy-induced neutropenia.

Produto acabado

Verificado a 2026-10-21

Pegfilgrastim: see suppliers →

Pembrolizumab

Brand: ZakAria (25 mg). Humanized anti-PD-1 monoclonal antibody. Melanoma, Merkel cell carcinoma, lung, head and neck cancer, lymphomas and other cancers.

Produto acabado

Verificado a 2026-10-21

Pembrolizumab: see suppliers →

Pertuzumab

Brand: Pectuna (30 mg). Anti-HER2 monoclonal antibody. Early and metastatic breast cancer.

Produto acabado

Verificado a 2026-10-21

Pertuzumab: see suppliers →

Recombinant COVID-19 Vaccine

Brand: SpikoGen (25 mcg). Recombinant SARS-CoV-2 Spike protein with Advax-SM adjuvant, produced in cooperation with Vaxine (Australia). Primary vaccination and booster.

Outro

Verificado a 2026-10-21

Somatropin

Brand: CinnaTropin (4, 10, 20 IU). Recombinant growth hormone in prefilled pen. Growth failure due to GH deficiency, Turner syndrome and other paediatric indications.

Produto acabado

Verificado a 2026-10-21

Somatropin: see suppliers →

Teriparatide

Brand: CinnoPar (250 mcg); Zandoriah in the EU. Recombinant human parathyroid hormone analogue, biosimilar to Forsteo. Postmenopausal, male and glucocorticoid-induced osteoporosis at high fracture risk.

Dictamen positivo CHMP

Registo submetido

Produto acabado

Verificado a 2026-10-21

Teriparatide: see suppliers →

Tirzepatide

Brand: Spartina (2.5–15 mg). Type 2 diabetes and weight loss and maintenance in adults.

Produto acabado

Verificado a 2026-10-21

Tirzepatide: see suppliers →

Contactar empresa

Registe-se gratuitamente para ver os dados de contacto desta empresa e escrever-lhe.

Registar - Gratuito